CD24 and cancer: The panel of basic antigens allowed us to discriminate the cancer and non-cancer phenotypes by CD24 expression and to show that in general, the cancer samples often demonstrate a “low-expressing” phenotype based on significantly diminished expression of CD24 (Fig 2C; S4 Fig).